Mbx Biosciences, Common Stock Today
| MBX Stock | 19.83 0.44 2.27% |
Performance6 of 100
| Odds Of DistressLess than 42
|
MBX Biosciences, is trading at 19.83 as of the 28th of November 2024; that is 2.27 percent up since the beginning of the trading day. The stock's open price was 19.39. MBX Biosciences, has about a 42 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for MBX Biosciences, Common are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of September 2024 | Category Healthcare | Classification Health Care |
MBX Biosciences, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 31.85 M outstanding shares of which 345.33 K shares are now shorted by investors with about 0.0 days to cover. More on MBX Biosciences, Common
Moving together with MBX Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
MBX Stock Highlights
MBX Biosciences, Common (MBX) is traded on NASDAQ Exchange in USA. It is located in 11711 N. Meridian Street, Carmel, IN, United States, 46032 and employs 38 people. MBX Biosciences, is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 676.25 M. MBX Biosciences, Common runs under Biotechnology sector within Health Care industry. The entity has 31.85 M outstanding shares of which 345.33 K shares are now shorted by investors with about 0.0 days to cover.
Check MBX Biosciences, Probability Of Bankruptcy
Ownership AllocationMBX Biosciences, Common maintains a total of 31.85 Million outstanding shares. Over half of MBX Biosciences,'s outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check MBX Ownership Details
MBX Biosciences, Historical Income Statement
MBX Stock Against Markets
MBX Biosciences, Corporate Management
| Michelle Graham | Chief Officer | Profile | |
| Salomon Azoulay | Chief Officer | Profile | |
| MBA MBA | Chief Officer | Profile | |
| Matt Gambino | Vice Marketing | Profile | |
| Richard CPA | Chief Officer | Profile |
Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.